{"id":2434,"date":"2025-01-14T18:31:17","date_gmt":"2025-01-14T15:31:17","guid":{"rendered":"https:\/\/dmdwarrior.com\/?p=2434"},"modified":"2025-01-14T18:31:19","modified_gmt":"2025-01-14T15:31:19","slug":"immunoforge-receives-fda-ind-approval-for-phase-2-clinical-trial-of-pemziviptadil-for-dmd-cardiomyopathy","status":"publish","type":"post","link":"https:\/\/dmdwarrior.com\/de\/immunoforge-receives-fda-ind-approval-for-phase-2-clinical-trial-of-pemziviptadil-for-dmd-cardiomyopathy\/","title":{"rendered":"ImmunoForge erh\u00e4lt FDA IND-Zulassung f\u00fcr klinische Phase-2-Studie zu \u201ePemziviptadil\u201c bei DMD-Kardiomyopathie"},"content":{"rendered":"<p class=\"wp-block-paragraph\">Pemziviptadil, ein Medikament gegen DMD-Kardiomyopathie, wird einmal w\u00f6chentlich angewendet und basiert auf der ELP-Plattform (Elastin Like Polypeptide Platform) von ImmunForge, einer pharmakologischen Plattform mit langer Wirkungsdauer. Um die Herzfunktion zu verbessern, wirkt Pemziviptadil, ein vasoaktives intestinales Peptid (VIP), bevorzugt auf den vasoaktiven intestinalen Peptidrezeptor 2 (VPAC2), um die Kontraktion und Entspannung des Herzens zu f\u00f6rdern.<\/p>","protected":false},"excerpt":{"rendered":"<p>Pemziviptadil, ein Medikament gegen DMD-Kardiomyopathie, wird einmal w\u00f6chentlich angewendet und basiert auf der ELP-Plattform (Elastin Like Polypeptide Platform) von ImmunForge, einer pharmakologischen Plattform mit langer Wirkungsdauer. Um die Herzfunktion zu verbessern, wirkt Pemziviptadil, ein vasoaktives intestinales Peptid (VIP), bevorzugt auf den vasoaktiven intestinalen Peptidrezeptor 2 (VPAC2), um die Kontraktion und Entspannung des Herzens zu f\u00f6rdern.<\/p>","protected":false},"author":1,"featured_media":2436,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[27],"tags":[66,156,157,159,158],"class_list":["post-2434","post","type-post","status-publish","format-standard","has-post-thumbnail","category-research","tag-duchenne-muscular-dystrophy","tag-immunoforge","tag-pemziviptadil","tag-pf1804","tag-south-korea"],"_links":{"self":[{"href":"https:\/\/dmdwarrior.com\/de\/wp-json\/wp\/v2\/posts\/2434","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dmdwarrior.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dmdwarrior.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/de\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/de\/wp-json\/wp\/v2\/comments?post=2434"}],"version-history":[{"count":0,"href":"https:\/\/dmdwarrior.com\/de\/wp-json\/wp\/v2\/posts\/2434\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/de\/wp-json\/wp\/v2\/media\/2436"}],"wp:attachment":[{"href":"https:\/\/dmdwarrior.com\/de\/wp-json\/wp\/v2\/media?parent=2434"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dmdwarrior.com\/de\/wp-json\/wp\/v2\/categories?post=2434"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dmdwarrior.com\/de\/wp-json\/wp\/v2\/tags?post=2434"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}